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Key Messages 
 Arrangements of an RRT programme resulted in an increased access to high-cost care 
in Thailand. 
 Dialysis registration was increasing in young patients.  




Based on projected numbers, approximately only 50% of those requiring renal replacement 
therapy (RRT) receive it. Many patients who require RRT live in low and middle income 
countries. The objective of this study was to examine the changing pattern over time of entry 
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into the renal replacement therapy programme in Thailand following RRT’s inclusion in the 
Universal Coverage Scheme. This study was an ecological study using the age-period-cohort 
analysis to look at dialysis registration and kidney transplant trends during RRT programme 
implementation. Data from 2008-2016 of patients diagnosed with end-stage renal disease 
(ESRD) were obtained from the National Health Security Office. The study found that the 
numbers of new patients with ESRD, aged 20-69, registered with the dialysis programme 
increased over time. For patients aged 20-40 years, the dialysis programme took up to 400 
new patients for every 1,000 new ESRD diagnoses. For kidney transplant, the rates increased 
slowly. The kidney transplant programme could at best treat only around 50 cases for every 
1,000 new ESRD diagnoses in patients aged 20-30 years. Findings of this study highlighted 
the importance of promoting strategies to reduce the increasing number of patients with 
kidney disease, to consider conservative therapy for older/frail patients, and improve access 






Chronic kidney disease has been increasingly recognised as a global public health problem, 
not only because of the rising prevalence across the world but also because of widening 
inequities in accessing renal replacement therapy (RRT) when kidney function has failed 
completely (Grassmann et al. 2005; White et al. 2008; Coresh and Jafar 2015; Liyanage et al. 
2015). It is estimated that, worldwide, only a half of those needing RRT receive it. Of those 
receiving RRT, only 9% reside in low- and middle-income countries, yet these people make 
up at least 38% of those who need the treatment (Liyanage et al. 2015). In these countries, the 
low percentage of people accessing treatment is a consequence of the unaffordable cost of 
dialysis (Jah 2013), arrangements of RRT service provision (Odubanjo, Oluwasola et al. 
2011), and variation in universal public reimbursement for services (Sakhuja and Kohli 2006; 
Pecoits–Filho et al. 2009). 
The Thai government launched the Universal Coverage Scheme (UCS) in 2001 to cover 
previously uninsured citizens outside the other two public schemes, namely, the Civil Servant 
Medical Benefit Scheme and the Social Security Scheme. To date, the UCS covers 48 million 
beneficiaries or 76% of Thais (NHSO 2017). RRT was initially excluded from the UCS 
benefit package due to fiscal constraints and lack of treatment facilities. The National Health 
Security Office (NHSO), which was responsible for the UCS, was increasingly pressured to 
expand benefits to include RRT, both dialysis and transplantation, by civil society 
organisations and patient groups (Tangcharoensathien et al. 2005). Despite being known to 
have poor cost-effectiveness relative to many other interventions (Sennfalt et al. 2002; 
Kontodimopoulos and Niakas 2008; Haller et al. 2011), in 2008 RRT was adopted into the 
benefit package of the UCS on the grounds that it would save lives and prevent indebtedness 
and health impoverishment among UCS members. The UCS introduced the RRT programme 
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as a so-called ‘disease management programme’ which would provide RRT services for 
every UCS member in need.  
The UCS-funded RRT adopted a ‘PD first’ policy, meaning that all new end-stage renal 
disease (ESRD) patients without contraindications must use continuous ambulatory 
peritoneal dialysis (CAPD) as first-line therapy, or shoulder the costs of hemodialysis (HD) 
themselves. HD patients who were on HD before the ‘PD first’ policy, and patients with 
contraindications to CAPD, were eligible for full reimbursement of the cost of HD. Under the 
PD-first policy, renal transplant and all essential high-cost medications are also included in 
the benefits (Chungsaman and Kasemsap 2017). When patients’ eGFR level reaches 15 
ml/minute per 1.73 m², they are diagnosed as ESRD. However according to the Thai 
Nephrology Society guidelines, UCS patients without signs or symptoms of kidney failure 
will be asked to enter the RRT programme once the eGFR level drops to 6 ml/minute per 
1.73 m2.  
Thailand, as a developing country, faces problems of inadequacy of health care infrastructure. 
To date, there has been limited study of the performance of the RRT programme. This study 
aimed to assess the changing patterns of entry into the RRT programme of adult UCS patients 
diagnosed with ESRD using an age-period-cohort analysis to establish whether launching the 
RRT programme promoted entry into the programme over time. 
Methods 
Data sources 
We undertook the age-period-cohort analysis using the administrative health databases of the 
UCS. These databases contain detailed demographic, diagnostic, procedures, medications, 
laboratory, and other clinical data at the individual level, and can be linked together and also 
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linked to mortality data from the Ministry of Interior’s civil registration system by using the 
13-digit citizen identification number. The NHSO has audit procedures to ensure quality as 
well as prevent duplicates of the claims data at both central and regional NHSO, and also has 
encoding processes for all citizen identification numbers before handing the data to any third 
party. 
Study population 
A cohort of patients who were diagnosed with ESRD was first constructed. It included adult 
UCS members aged 20 to 69 who had an index hospitalisation or outpatient visit with an 
ESRD diagnosis (ICD-10 code N180 or N185) as either primary diagnosis or secondary 
diagnosis between 1 January 2008 (the date RRT was adopted into the UCS benefit package) 
and 31 December 2016. After that, any cohort member who received an RRT modality: 
dialysis (either peritoneal dialysis or hemodialysis) and kidney transplant, were identified. 
The study also included anyone who had modality changes, mostly from peritoneal dialysis to 
hemodialysis, during the study period. It excluded self-paying hemodialysis patients 
(approximately 1,700 new UCS patients per year) and patients who had a history of 
temporary dialysis treatment in a period shorter than 30 days. This included patients who 
started dialysis then were lost to follow-up or died within 30 days; also those who were 
registered into the RRT programme less than 30 days before the census date (31 December 
2016). Since the RRT programme was designed to cover patients with established renal 
failure, those who were diagnosed with acute/reversible renal failure were not included in the 
database.   
Data analysis 
Age of entry into the RRT programme was determined by the time (year) between the date of 
birth and the date of dialysis registration or receiving a kidney transplant. ‘Cohort’ was the 
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individuals’ years of birth. The ‘period’ denoted calendar years of the period studied. 
Individuals were grouped into 10 five-year age at registration (or at transplantation) groups 
(aged 20-69), and 11 five-year cohort groups (from 1942-1996). Period was used as a single 
year interval (from 2008-2016). The age standardised registration rates were estimated for 
each year of the period studied using the World Health Organization’s world population in 
the year 2000 as the standard.  
In the age-period-cohort model, a set of nested models (likelihood-ratio test) was used to 
compare the goodness-of-fit within a set of models. This was done by first comparing the 
deviance of any model that deviated from linear effects (the null model which contained only 
the age parameter). The deviance was then compared in this manner until the deviance of the 
last pair of models was obtained. The preferred model was selected by the lowest deviance. 
Finally, the effects of the key variables (age, period, and cohort) were estimated by using a 
log-linear Poisson regression. For parameterisation, drift was extracted by the weight average 
method. Knots (parameters) were equally spaced. Equal numbers of knots were allocated to 
age, period and cohort. The study used five knots in all models. Data analyses and graphical 
presentations were conducted by Stata version 12. Modelling was carried out using the apcfit 
command (Rutherford, Thompson et al. 2012). All confidence intervals are 95% confidence 
intervals. 
Results 
Overall, numbers of new patients with ESRD, aged 20-69, registered with the dialysis 
programme, increased over time and the total number of new registrations in the period was 
56,238 (Table 1).  
<Table 1 here> 
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Over time, there were a larger number of cases, yet fairly constant rates in the young age-
groups. Overall rates of people with dialysis registration started at 100 per million population 
(pmp) in 2008 (equivalent to current UK dialysis take on rates) and increased continuously 
over time to approximately 200 pmp around 2014, then plateauing at that level. Despite a 
constant increase in dialysis take on over time, kidney transplant rates were low across all age 
groups, in particular for those over 60 years. The total numbers of ESRD patients who had a 
kidney transplant was at its highest point in 2013, at around 150 cases, then fell to just above 
100 cases in 2014 to 2015 and climbed back to 150 cases again in 2016 (Table 2). 
<Table 2 here> 
Although the registration rate in 2008 was low at the start of the programme, and the rates of 
all age groups were very close at first (20%-30% of ESRD diagnoses), by 2012, the rates had 
risen to a peak across most age groups and then dialysis take on gradually decreased in 
successive years for the age groups of 55 or more years, and particularly for the older age 
groups. Over the nine-year period, it is clear that the approach to dialysing older people 
changed, fewer older people started dialysis after the peak in 2012. Consequently, a wide gap 
in registration rates developed with the rates ranging from 10%-50% of ESRD diagnoses 
(Figure 1a). For kidney transplantation, the rates showed high peaks in some specific years 
and very young age groups (Figure 1b). These numbers need to be seen not just in the context 
of rates per million population, but also in terms of available facilities to deliver these 
interventions. Total numbers of available dialysis take-on slots have remained constant since 
2015, and also the capacity for kidney transplantation. The total numbers of transplants, 
particularly in patients aged 40 years and above, have not changed much since 2014. In 2016 
the transplant rates ranged from 0%-5% of ESRD diagnoses (Figure 1b).  
<Figure 1 here> 
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In the reference year 2014, the effects of age on dialysis were strongest for patients aged 20-
40 years. The dialysis programme could take up to 400 new patients of this age group for 
every 1,000 new ESRD diagnoses (Figure 2a). The dialysis programme saw many more new 
registrations than the transplant programme, which could treat at best only around 50 cases 
for every 1,000 new ESRD diagnoses in patients aged 20 (Figure 2c). From 2009, the dialysis 
programme showed an upward trend in registrations and the trend started to decline after 
2012 (Figure 2b). For kidney transplantation, after a sharp increase between 2008 and 2010, 
rates increased slowly over time until 2016 (Figure 2d).  
<Figure 2 here> 
Discussion 
The RRT programme intended to provide access to essential healthcare and prevent 
UCS beneficiaries incurring financially catastrophic payments due to expensive 
treatment.  It has achieved these aims by enrolling ESRD patients into the programme 
regardless of age or socioeconomic status and it is the NHSO who pays for service costs 
not patients.  
The study assessed rates of registration into the RRT programme by the age-period-cohort 
method.  The dialysis registration rate is likely to have responded to the new policy since 
registration trends increased after each change in reimbursement policy. Dialysis centres and 
professionals started to be available nationwide from 2009 onwards (NHSO 2017). With 
availability of services, previously unrecognised cases with ESRD were identified and 
registered. Hence, registration rates began to increase sharply in the 24 months following the 
introduction of the programme in 2008. An increase was also evident when the NHSO started 
to reimburse treatment for UCS patients who had previously refused the PD-first policy, and 
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allowed them to register for free hemodialysis. This additional benefit is likely to have 
boosted the dialysis registration rate after 2014.  
It was evident that not all patients started RRT once they were newly diagnosed with ESRD. 
More than half of all ESRD patients were not registered into the dialysis programme. In 
addition, after dialysis registrations reached a peak in 2012, the RRT programme was able to 
enroll a higher percentage of young patients needing RRT; however the registration rates 
tended to decrease with age, despite the high and growing proportion of older patients with 
ESRD diagnoses.  
There are two likely explanations of these findings. Firstly, the guideline of taking up patients 
into the RRT programme developed by the Thai Nephrology Society recommended that 
patients with ESRD diagnoses without signs or symptoms of kidney failure should be asked 
to register into the RRT programme when their eGFR levels dropped to 6 ml/minute per 1.73 
m2. The principle of waiting until the eGFR was low was based on the IDEAL trial (Cooper 
et al. 2010).  
Secondly, for the low registration rates in elderly patients, the finding corresponds to that of 
some prior studies (Morton et al. 2010; Rayner et al. 2014; Tonkin-Crine et al. 2015; 
Thammatacharee 2016) that the elderly with ESRD, who have multiple illnesses and lack 
family support, are likely to be unable to use or may refuse to start dialysis. This is less likely 
to be a supply side issue, since in the UCS, the guideline of RRT registration does not 
indicate an age limit and the payment to the RRT programme is based on the number of 
registrations. So the more patients are registered, the greater the amount of reimbursement to 
dialysis centres.  
When comparing RRT with other health care interventions, RRT modalities are usually 
ranked as providing inferior value for money expressed in terms of incremental cost-
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effectiveness ratios (ICER) (Chaikledklew 2014). Thailand took the decision to include RRT 
in the UCS benefit package due to concern about inequalities with the health benefit packages 
of other social insurance schemes, and evidence of the impoverishing effects of payment for 
treatment for affected people and their families. Results from other literature have indicated 
that HD is the least cost-effective treatment option, while continuous ambulatory peritoneal 
dialysis and kidney transplant represent more cost-effective approaches (Sennfalt et al. 2002; 
Kontodimopoulos and Niakas 2008; Haller et al. 2011). While renal dialysis is less cost-
effective in comparison to transplantation (Muirhead 1996) but it is essential to prolong a 
patient’s life and since organ donors tend to be in short supply, transplantation is not 
available to every patient.  
Thailand has introduced many strategies to promote organ donation, for example patients are 
asked on admission whether they wish to donate their organs, an online organ registration 
system has been set up, and a number of organ donation campaigns launched. These 
strategies have encouraged growth in the number of donations, in particular from deceased 
donors (Thai Transplantation Society 2017). Nonetheless the kidney transplant rate in 
Thailand was approximately 8 pmp (Chuasuwan and Praditpornsilpa 2015) which was low in 
comparison to other countries worldwide (GODT 2017). This study found that the kidney 
transplant rate of UCS patients was 3 pmp. At this rate, it accounted for just one-third of all 
kidney transplants in Thailand, despite the fact that the UCS is the largest public health 
scheme and covers 76% of all Thais.  
This study found that the incidence of RRT registrations among UCS patients was very high 
(200 pmp). Assuming that this number accounted for 50% of all ESRD patients, the incidence 
of ESRD in Thailand may be one of the highest in the world, comparable to countries with 
the highest ESRD incidence like Taiwan (476 pmp), the Jalisco region of Mexico (411 pmp), 
and the United States (376 pmp) (United States Renal Data System 2017). This highlights 
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that chronic kidney disease is very important for Thailand, and that prevention of people 
requiring dialysis is needed. Especially for diabetes there is good evidence that the need to 
dialysis can be prevented by blood pressure and diabetes treatment.  
A systematic review estimated that around the world in 2010, there were 9.7 million patients 
needing renal replacement therapy (RRT) but only 2.6 million patients were able to use it. 
The proportion of those in need but not receiving RRT ranged from just 5% in North America 
to 91% in Africa (Liyanage et al. 2015). Variations among different regions were found to be 
more associated with supply-side factors (such as macroeconomic issues, health systems, and 
renal service provision) rather than health status or demographics of the general population 
(Caskey et al. 2011).  
Evidence of inequalities due to the insurance system and RRT provision also exists in other 
lower-middle income countries. For example in Mexico, chronic kidney disease was a serious 
health problem but only Social Security System beneficiaries (48% of the overall population) 
had access to RRT benefits. The public insurance programme that covered the rest of 
population did not include RRT services (Pecoits–Filho et al. 2009; Garcia-Garcia and 
Chavez-Iñiguez 2018). In Malaysia, the government is the main source of funding for dialysis 
(63%). These funds are channeled as subsidies to non-profit HD centres and as payment for 
dialysis treatment for pensioners, civil servants and their dependents in private HD centres. 
Patients without these subsidies pay themselves or receive charitable support (Ahmad et al., 
2015). Thailand introduced the current service on the grounds that it would save lives and 
prevent indebtedness and health impoverishment among UCS members and their families.  
In Thailand, chronic kidney disease was not ranked as a topmost health problem in terms of 
deaths and disability. It was reported to be an underlying condition in patients with 
hypertension, diabetes, high uric acid, and using traditional medicines (Ingsathit et al. 2009). 
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It is not surprising, after all chronic kidney disease is frequently asymptomatic until patients 
reach ESRD, and in the absence of diagnostic services may be misdiagnosed as another 
condition. Apart from hypertension and diabetes, chronic glomerulonephritis was one of the 
main primary diagnoses among those who had ESRD and later underwent kidney transplant 
(Thai Transplantation Society 2017). The government has been launching many health 
promotion and prevention programmes to control non-communicable diseases but it is too 
early to look for positive results in relation to ESRD from these programmes, as ESRD 
develops over decades in frequently asymptomatic individuals. 
This study was a facility-based study which enhanced validity by capturing most individuals 
of interest and results were representative of the studied population. In addition, the age-
period-cohort analysis is regarded as a powerful tool in modelling and analysing routinely 
collected information from administrative records or disease registries (Carstensen 2007). 
This study has some limitations. The age-period-cohort analysis does not establish a cause-
effect relationship to prove whether the RRT programme really caused an effect on the 
outcome of interest (registration). In addition, the secondary data used in this analysis were 
mainly intended for administrative purposes, and thus had limitations. For example, data for 
many fields which were not used for budget claims, such as laboratory results, were not 
routinely recorded. 
To date, there is still a lack of reliable epidemiological information on the various stages 
of chronic kidney disease in the general population. This is because it is a silent disease: 
a patient may be living asymptomatically until the condition reaches an advanced stage. 
Patients who receive RRT can be used to identify the number of patients with last-stage 
chronic kidney disease, however numbers of patients in this sense reflect only the 
portion of patients who receive treatment and cannot be used to represent the entire 
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affected population, or even the number of patients with ESRD (Eustace and Coresh 
2005).  
Conclusions 
Thailand is unusual as a middle income country in having opened access to RRT for its whole 
population. It did this by including RRT in the benefit package of the UCS and expanding 
treatment resources. This paper provides evidence that rates of registration increased, 
especially for younger groups whereas older people may have been less willing to enter 
treatment and may benefit from conservative management programmes. Transplantation rates 
remain too low, and it is hoped that kidney live-donation programmes can be established. 
Policy makers should find strategies to reduce the increasing number of patients with kidney 
disease who later develop ESRD.  
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Table 1  Numbers of dialysis registrations (n) and age-standardised rates of dialysis registration for 
patients aged 20-69 years, 2008-2016 
Year 
20-39 yrs 40-59 yrs 60-69 yrs Overall 
n Rate* n Rate* n Rate* n Crude rate* 
Adjusted 
rate* 
2008 604 49 2139 170 417 131 3160 113 103 
2009 467 38 1718 133 407 122 2592 91 83 
2010 601 49 2503 191 812 232 3916 136 123 
2011 735 62 3036 227 1238 330 5009 173 154 
2012 824 67 3496 258 1732 454 6052 204 182 
2013 1039 86 4371 321 2556 638 7966 268 235 
2014 1029 51 4714 242 3087 595 8830 198 183 
2015 1063 54 4867 248 3458 637 9388 209 191 
2016 1069 54 4771 240 3485 611 9325 206 186 





Table 2  Numbers of new kidney transplants (n) and age-standardised rates of kidney transplants 
for patients aged 20-69 years, 2008-2016 
Year 
20-39 yrs 40-59 yrs 60-69 yrs Overall 
n Rate* n Rate* n Rate* n Crude rate* Adjusted rate* 
2008 7 1 3 0 0 0 10 0 0 
2009 17 1 10 1 1 0 28 1 1 
2010 27 2 17 2 1 0 55 2 2 
2011 40 3 24 2 2 1 66 2 2 
2012 29 2 25 2 4 1 58 2 2 
2013 61 5 76 6 9 2 146 5 5 
2014 40 2 69 4 10 2 119 3 3 
2015 54 3 62 3 6 1 122 3 3 
2016 65 3 78 4 8 1 151 3 3 
*rate per million UCS population years within each age group 
 
 
Figure 1 Figure 1 Dialysis registration (a) and kidney transplant (b) rates per 1000 ESRD 









Figure 2 Effects of age (a and c) and period (b and d) on dialysis registrations and 
transplant (rates per 1000 ESRD diagnoses). 
 
